Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-751 with Chemotherapy in Relapsed ALL
NCT00439296Phase 2Terminated
- Sponsor
- Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium
- Start
- May 2006
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abt-751 in acute lymphoblastic leukemia (ALL), sponsored by Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium. Started May 2006; status: terminated.
02
Drugs
abt-751
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00439296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439296.